Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pink

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Peptides|August 5, 2003
Regulation of TNF-alpha secretion by a specific melanocortin-1 receptor peptide agonistDiane M Ignar, John L Andrews, Marilyn Jansen, et al.
Inorganic Chemistry|September 18, 2001
Synthesis, isolation, and characterization of trisodium tricarbonyliridate (3-), Na3[Ir(CO)3]. Initial studies on its derivative chemistry and structural characterizations of trans-[Ir(CO)3(EPh3)2](-), E = Ge, Sn, and trans-[Co(CO)3(SnPh3)2](-1)J M Allen, W W Brennessel, C E Buss, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacyD F Emerich, P Snodgrass, R L Dean, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumorsD F Emerich, R L Dean, P Snodgrass, et al.
Inorganic Chemistry|March 7, 2001
Coaggregation of paramagnetic d- and f-block metal ions with a podand-framework amine phenol ligandZ Xu, P W Read, D E Hibbs, et al.
Molecular Cancer Therapeutics|December 3, 2009
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivoMark Douglas, Alice R Lim, James R Porter, et al.
Viruses|February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysGregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Chemistry & Biology|November 12, 2013
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease modelsDavid G Winkler, Kerrie L Faia, Jonathan P DiNitto, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Peptides|August 5, 2003
Regulation of TNF-alpha secretion by a specific melanocortin-1 receptor peptide agonistDiane M Ignar, John L Andrews, Marilyn Jansen, et al.
Inorganic Chemistry|September 18, 2001
Synthesis, isolation, and characterization of trisodium tricarbonyliridate (3-), Na3[Ir(CO)3]. Initial studies on its derivative chemistry and structural characterizations of trans-[Ir(CO)3(EPh3)2](-), E = Ge, Sn, and trans-[Co(CO)3(SnPh3)2](-1)J M Allen, W W Brennessel, C E Buss, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacyD F Emerich, P Snodgrass, R L Dean, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumorsD F Emerich, R L Dean, P Snodgrass, et al.
Inorganic Chemistry|March 7, 2001
Coaggregation of paramagnetic d- and f-block metal ions with a podand-framework amine phenol ligandZ Xu, P W Read, D E Hibbs, et al.
Molecular Cancer Therapeutics|December 3, 2009
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivoMark Douglas, Alice R Lim, James R Porter, et al.
Viruses|February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysGregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Chemistry & Biology|November 12, 2013
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease modelsDavid G Winkler, Kerrie L Faia, Jonathan P DiNitto, et al.
Pageof 11